We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+26.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62.3B
AUM Growth
+$13.8B
Cap. Flow
+$3.01B
Cap. Flow %
4.83%
Top 10 Hldgs %
42.27%
Holding
775
New
54
Increased
269
Reduced
324
Closed
89

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$751M
2
PG icon
Procter & Gamble
PG
+$623M
3
NVO
Novo Nordisk
NVO
+$579M
4
MRK icon
Merck
MRK
+$440M
5
YUMC icon
Yum China
YUMC
+$153M

Sector Composition

Rank Sector Weight
1 Technology 26.89%
2 Consumer Discretionary 16.68%
3 Healthcare 12.96%
4 Communication Services 12.75%
5 Financials 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
26
Colgate-Palmolive
CL
$74.4B
$798M 1.28%
10,898,399
+183,366
+2% +$13M
BMY icon
27
Bristol-Myers Squibb
BMY
$132B
$798M 1.28%
13,576,819
-12,187
-0.1% -$729K
WDAY icon
28
Workday
WDAY
$44.4B
$754M 1.21%
4,027,000
+1,123,525
+39% +$182M
T icon
29
AT&T
T
$163B
$729M 1.17%
31,916,221
+64,421
+0.2% +$1.47M
YUM icon
30
Yum! Brands
YUM
$41.1B
$618M 0.99%
7,113,435
+98,533
+1% +$8.42M
ISRG icon
31
Intuitive Surgical
ISRG
$134B
$558M 0.9%
2,938,695
+2,270,106
+340% +$407M
YUMC icon
32
Yum China
YUMC
$16.3B
$535M 0.86%
11,128,282
-3,246,578
-23% -$153M
NVO
33
Novo Nordisk
NVO
$209B
$482M 0.77%
14,729,714
-18,137,576
-55% -$579M
SLB icon
34
SLB Ltd
SLB
$75B
$373M 0.6%
20,298,192
+429,363
+2% +$7.52M
ADP icon
35
Automatic Data Processing
ADP
$108B
$369M 0.59%
2,480,292
+20,780
+0.8% +$2.98M
VAR
36
DELISTED
Varian Medical Systems, Inc.
VAR
$330M 0.53%
2,691,256
-429,507
-14% -$49.7M
GLW icon
37
Corning
GLW
$143B
$259M 0.42%
9,982,746
-400,271
-4% -$9.07M
DHR icon
38
Danaher
DHR
$144B
$255M 0.41%
1,625,237
-334,811
-17% -$48.1M
ROP icon
39
Roper Technologies
ROP
$39.8B
$244M 0.39%
629,090
-100,852
-14% -$36.1M
MA icon
40
Mastercard
MA
$493B
$214M 0.34%
725,317
+347,341
+92% +$97.9M
UNH icon
41
UnitedHealth
UNH
$370B
$209M 0.33%
707,207
-155,885
-18% -$44.7M
SPGI icon
42
S&P Global
SPGI
$120B
$206M 0.33%
623,937
-148,209
-19% -$44.6M
IQV icon
43
IQVIA
IQV
$39.3B
$202M 0.32%
1,420,612
-91,182
-6% -$12.4M
LIN icon
44
Linde
LIN
$226B
$201M 0.32%
947,028
+87,255
+10% +$16.8M
ACN icon
45
Accenture
ACN
$108B
$185M 0.3%
859,802
-78,902
-8% -$14.9M
EL icon
46
Estee Lauder
EL
$32B
$178M 0.29%
941,339
+59,402
+7% +$10.6M
BDX icon
47
Becton Dickinson
BDX
$48.2B
$160M 0.26%
685,451
-39,000
-5% -$9.4M
F icon
48
Ford
F
$55.7B
$150M 0.24%
24,609,157
-64,989
-0.3% -$360K
MTB icon
49
M&T Bank
MTB
$36.2B
$139M 0.22%
1,335,052
+464,807
+53% +$49.1M
TXN icon
50
Texas Instruments
TXN
$261B
$135M 0.22%
1,062,729
-40,560
-4% -$4.73M

Similar funds

Loomis, Sayles & Company's Q2 2020 Portfolio in Review

As of Q2 2020, Loomis, Sayles & Company held 775 positions worth $62.3B, up 28% from $48.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Loomis, Sayles & Company deployed $3.01B of net new capital in Q2 2020, opening 54 new positions and adding to 269 existing holdings. Its largest new stake was Dropbox: 3,912,402 shares worth $85.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $751M trimmed.

  • Loomis, Sayles & Company's largest Q2 2020 buy was Dropbox: 3,912,402 shares worth $85.2M.
  • Loomis, Sayles & Company added most to Bank of America Series L in Q2 2020, an estimated $1.47B increase.
  • Loomis, Sayles & Company's biggest Q2 2020 reduction was Amgen, cutting an estimated $751M.
  • Loomis, Sayles & Company fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $32.2M.
  • Loomis, Sayles & Company's ten largest holdings make up 42% of its $62.3B portfolio in Q2 2020.
  • Loomis, Sayles & Company opened 54 new positions and closed 89 in Q2 2020.
  • Loomis, Sayles & Company's portfolio value rose 28% quarter-over-quarter to $62.3B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2020, filed 14 Aug 2020.